ImmuDyne Signs Exclusive License Agreement for Clinically-Backed Solar Purpura Product
NEW YORK, March 28, 2018 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. (OTCQB:IMMD) (“Immudyne” or the “Company”), a leader in the development and marketing of Over-the-Counter healthcare products, is pleased to announce the signing of an exclusive license to …